Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3422.37 | 1445 / 1445 | 100% | 54.19 | 183 / 183 |
lung | 100% | 3096.01 | 578 / 578 | 100% | 64.69 | 1155 / 1155 |
ovary | 100% | 2923.71 | 180 / 180 | 100% | 55.95 | 430 / 430 |
pancreas | 100% | 1805.67 | 328 / 328 | 100% | 65.60 | 178 / 178 |
prostate | 100% | 2849.96 | 245 / 245 | 100% | 72.46 | 502 / 502 |
stomach | 100% | 2689.45 | 359 / 359 | 100% | 60.35 | 286 / 286 |
uterus | 100% | 3036.89 | 170 / 170 | 100% | 61.51 | 459 / 459 |
kidney | 100% | 3693.63 | 89 / 89 | 100% | 59.84 | 900 / 901 |
brain | 100% | 2456.23 | 2639 / 2642 | 100% | 67.51 | 705 / 705 |
intestine | 100% | 3149.38 | 966 / 966 | 100% | 66.32 | 526 / 527 |
skin | 100% | 3710.52 | 1809 / 1809 | 100% | 73.40 | 471 / 472 |
breast | 100% | 3601.23 | 459 / 459 | 100% | 83.04 | 1115 / 1118 |
thymus | 100% | 3298.03 | 653 / 653 | 100% | 70.48 | 603 / 605 |
liver | 100% | 1751.29 | 225 / 226 | 100% | 47.41 | 406 / 406 |
bladder | 100% | 3099.14 | 21 / 21 | 99% | 58.76 | 501 / 504 |
adrenal gland | 100% | 3929.96 | 258 / 258 | 99% | 62.04 | 228 / 230 |
adipose | 100% | 3470.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3435.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 66.65 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.91 | 29 / 29 |
muscle | 100% | 4029.42 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2889.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 60.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.81 | 1 / 1 |
peripheral blood | 99% | 2788.18 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 2762.07 | 855 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0001558 | Biological process | regulation of cell growth |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0046755 | Biological process | viral budding |
GO_0016236 | Biological process | macroautophagy |
GO_0051301 | Biological process | cell division |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0090148 | Biological process | membrane fission |
GO_0043405 | Biological process | regulation of MAP kinase activity |
GO_0036211 | Biological process | protein modification process |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0019076 | Biological process | viral release from host cell |
GO_1903774 | Biological process | positive regulation of viral budding via host ESCRT complex |
GO_1990182 | Biological process | exosomal secretion |
GO_2000397 | Biological process | positive regulation of ubiquitin-dependent endocytosis |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_0097352 | Biological process | autophagosome maturation |
GO_0006858 | Biological process | extracellular transport |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0043328 | Biological process | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_1903551 | Biological process | regulation of extracellular exosome assembly |
GO_0005730 | Cellular component | nucleolus |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005813 | Cellular component | centrosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0000813 | Cellular component | ESCRT I complex |
GO_0090543 | Cellular component | Flemming body |
GO_0005829 | Cellular component | cytosol |
GO_0005770 | Cellular component | late endosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005771 | Cellular component | multivesicular body |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0046790 | Molecular function | virion binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | TSG101 |
Protein name | Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) Tumor susceptibility protein isoform 3 (Tumor susceptibility protein isoform 4) Tumor susceptibility protein 101 Tumor susceptibility 101 |
Synonyms | |
Description | FUNCTION: Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Mediates the association between the ESCRT-0 and ESCRT-I complex. Required for completion of cytokinesis; the function requires CEP55. May be involved in cell growth and differentiation. Acts as a negative growth regulator. Involved in the budding of many viruses through an interaction with viral proteins that contain a late-budding motif P-[ST]-A-P. This interaction is essential for viral particle budding of numerous retroviruses. Required for the exosomal release of SDCBP, CD63 and syndecan . It may also play a role in the extracellular release of microvesicles that differ from the exosomes . . |
Accessions | J3QKS4 J3QRU6 F5H442 ENST00000580814.1 Q99816 ENST00000584526.1 Q86SI0 L0L6B6 ENST00000251968.4 [Q99816-1] ENST00000536719.5 |